EMA Urges The Withdrawal of Pholcodine Drugs From EU Market
PRAC, EMA's safety committee, has completed its review of pholcodine-containing medications used to treat nonproductive (dry) cough in adults and...
PRAC, EMA's safety committee, has completed its review of pholcodine-containing medications used to treat nonproductive (dry) cough in adults and...
With 100 vaccine candidates as of July 2022, Vaccines Europe has released its first pipeline evaluation of the 15 firms...
A recent analysis from GlobalData estimates that by 2028, the approval of pipeline drugs will earn over $2 billion from...
What changes are in store for the European Human Medicines Directive and Regulation when it is amended at the end...
Researchers at Chalmers University of Technology in Sweden have created synthetic DNA that directs the cellular creation of proteins with...
A multi-drug, precision medicine trial involving Roche, the University of Manchester, and Cancer Research UK has begun for patients with...
Clinical trials have expanded from 2,119 in 2000 to over 409,000 in 2022 (and counting). Not only has the number...
There is a new medicine that has surpassed Bluebird Bio as the costliest in the world. Hemgenix, a haemophilia B...
As the world's pharmacy, India had a 138% growth in pharmaceutical exports from April through October 2022–23 compared to the...
In an effort to advance personalised cancer treatment, researchers have shown that biomarkers alone cannot predict which patients will benefit...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.